- Home
- AVBP vs IRMD Comparison
AVBP vs IRMD Comparison
Compare AVBP & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVBP
- IRMD
- Stock Information
- Founded
- AVBP 2021
- IRMD 1992
- Country
- AVBP United States
- IRMD United States
- Employees
- AVBP N/A
- IRMD N/A
- Industry
- AVBP
- IRMD Medical/Dental Instruments
- Sector
- AVBP
- IRMD Health Care
- Exchange
- AVBP NYSE
- IRMD Nasdaq
- Market Cap
- AVBP 862.8M
- IRMD 756.5M
- IPO Year
- AVBP 2024
- IRMD 2014
- Fundamental
- Price
- AVBP $21.63
- IRMD $58.02
- Analyst Decision
- AVBP Strong Buy
- IRMD Strong Buy
- Analyst Count
- AVBP 8
- IRMD 1
- Target Price
- AVBP $38.38
- IRMD $72.00
- AVG Volume (30 Days)
- AVBP 484.4K
- IRMD 67.2K
- Earning Date
- AVBP 08-13-2025
- IRMD 07-31-2025
- Dividend Yield
- AVBP N/A
- IRMD 1.14%
- EPS Growth
- AVBP N/A
- IRMD 10.72
- EPS
- AVBP N/A
- IRMD 1.55
- Revenue
- AVBP N/A
- IRMD $75,154,639.00
- Revenue This Year
- AVBP $85.82
- IRMD $10.62
- Revenue Next Year
- AVBP N/A
- IRMD $9.69
- P/E Ratio
- AVBP N/A
- IRMD $38.37
- Revenue Growth
- AVBP N/A
- IRMD 11.04
- 52 Week Low
- AVBP $15.47
- IRMD $42.34
- 52 Week High
- AVBP $36.37
- IRMD $63.29
- Technical
- Relative Strength Index (RSI)
- AVBP 47.74
- IRMD 46.18
- Support Level
- AVBP $19.71
- IRMD $58.44
- Resistance Level
- AVBP $22.32
- IRMD $60.85
- Average True Range (ATR)
- AVBP 1.32
- IRMD 1.62
- MACD
- AVBP -0.20
- IRMD -0.40
- Stochastic Oscillator
- AVBP 31.89
- IRMD 8.87
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.